Tag: FDA

• 
  BioNTech Boris Johnson COVID-19 vaccine Dow Jones Industrial Average FDA Moderna Nasdaq Composite Pfizer Pfizer and BioNTech vaccine S&P 500 Борис Джонсон вакцина Pfizer и BioNTech вакцина Pfizer і BioNTech вакцина проти COVID-19 вакцина против COVID-19 Индекс Dow Jones Industrial Average Індекс Dow Jones Industrial Average

  Pfizer will deliver half of the planned number of vaccines in 2020

  Shares of Pfizer and BioNTech fell 1.74% and 2% (respectively) on Thursday amid news that companies will deliver half of their planned number of vaccines against COVID-19 in 2020. On November 20, Pfizer and its German partner BioNTech applied to the FDA (US Food and Drug Administration) for permission to use their vaccine in an […]

• 
  BioNTech COVID-19 Donald Trump FDA Pfizer vaccine against COVID-19 вакцина проти COVID-19 вакцина против COVID-19 Дональд Трамп

  Pfizer submits the application to the FDA for permission to use the emergency vaccine of COVID-19 in November

  Shares of the largest US pharmaceutical company Pfizer, down to 3.14% since the beginning of the year, rose to 3.83% on Friday on good news about its vaccine against the COVID-19. Currently, the mTNA candidate vaccine of BNT162b1, developed by Pfizer in the partnership with the German company BioNTech, the mechanism of the action of […]

• 
  AbCellera Biologics coronavirus COVID-19 drugs COVID-19 pandemic Eli Lilly FDA Regeneron US President Donald Trump коронавирус коронавірус пандемия COVID-19 пандемія COVID-19 Президент США Дональд Трамп препарати від COVID-19 препараты от COVID-19

  Eli Lilly and Regeneron have requested the permission for the emergency use of drugs from COVID-19

  Eli Lilly and Regeneron have applied to the Food and Drug Administration (FDA) for the permission to use emergency coronavirus drugs. Eli Lilly conducted clinical trials with the placebo group, as a result of which the drug has proven its antiviral action. Regeneron did not provide the research data, but the company’s drug was widely […]

• 
  BioNTech vaccine BNT162b1 vaccine COVID-19 vaccine FDA Moderna Nasdaq-100 Pfizer vaccine SARS-CoV-2 vaccine вакцина BioNTech вакцина BNT162b1 вакцина Pfizer вакцина проти COVID-19 вакцина проти SARS-CoV-2 вакцина против COVID-19 вакцина против SARS-CoV-2

  The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities

  Pfizer and BioNTech shares rose sharply on Monday by 4% and 10%, respectively. This happened after the US Food and Drug Administration (FDA) assigned an “accelerated” status to their two COVID-19 potential vaccines. Although the companies have not yet completed the final tests and have not received approval for the production and sale of their […]